Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Firategrast: natalizumab in a pill?
Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.
Siponimod (BAF312) for the Treatment of Secondary Progressive Multiple Sclerosis: Design of the Phase 3 EXPAND Trial
Primary results of DECIDE: a randomized, double-blind, double-dummy, active-controlled trial of daclizumab HYP vs. Interferon β-1a in RRMS patients
Improving the translational hit of experimental treatments in multiple sclerosis.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
The molecular basis of nutritional intervention in multiple sclerosis: a narrative review.
A timing-of-birth effect on multiple sclerosis clinical phenotype.
A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio.
Estrogens, Neuroinflammation and Neurodegeneration.
Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation.
Sodium intake is associated with increased disease activity in multiple sclerosis.
Effirma, Synthetic Biologics
Letter to the Editor: Trigeminal neuralgia in patients with multiple sclerosis.
Advanced MRI and staging of multiple sclerosis lesions.
Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.
MS research gears up for new drugs
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
MRI monitoring of spinal cord changes in patients with multiple sclerosis.
Making Treatment & Lifestyle Decisions: Thinking About Benefits & Risks